Posted inComunicati
Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE SUZHOU, China and MÖLNDAL, Sweden, Oct. 8, 2026 /PRNewswire/ --…
diretta News